Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-08-14 | D/A | $14.9M | 5 | |
| 2026-07-16 | D/A | $16.1M | 5 | +$1.2M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Renaissance Institutional Equities vehicles →
Sold rose to $NaN (+$1.2M) in 336 days since the previous filing.
Sold rose to $NaN (+$73.8M, +18 investors) in 335 days since the previous filing.
| Edward F. Hubner | Executive Officer |
| Mark F. Silber | Director |
| Dr. Marilyn K. Simons | Director |
| Dr. Peter F. Brown | Executive Officer, Director |
| Dr. Robert T. Lourie | Director |
| Nathaniel H. Simons | Director |
| Tiffany T. Michel | Executive Officer |
| Dr. Henry F. Laufer | Director |
| Brian F. Felczak | Executive Officer |
| Dr. David K. Lippe | Executive Officer, Director |
| Anne K. Small | Executive Officer, Director |
Signed by Tiffany T. Michel, Chief Compliance Officer & Deputy General Counsel of the GP.
Relevant to: Fund audit & tax, Fund administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans.
